Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma

Although regulatory T cells (Tregs) play an integral role in immunologic tolerance and the maintenance of intestinal homeostasis, their involvement in canine gastrointestinal diseases, including idiopathic inflammatory bowel disease (IBD) and intestinal lymphoma, remains unclear. Here we show altered numbers of forkhead box P3 (Foxp3)–positive Tregs in the intestine of dogs with IBD and intestinal lymphoma. IBD was diagnosed in 48 dogs; small cell intestinal lymphoma was diagnosed in 46 dogs; large cell intestinal lymphoma was diagnosed in 30 dogs; and 25 healthy beagles were used as normal controls. Foxp3-positive Tregs in the duodenal mucosa were examined by immunohistochemistry and immunofluorescence. Duodenal expression of interleukin-10 mRNA was quantified by real-time reverse transcription polymerase chain reaction. The number of Foxp3-positive lamina propria cells and the expression of interleukin-10 mRNA were significantly lower in dogs with IBD than in healthy dogs and dogs with intestinal lymphoma. The number of Foxp3-positive intraepithelial cells was higher in dogs with small cell intestinal lymphoma. Some large cell intestinal lymphoma cases had high numbers of Foxp3-positive cells, but the increase was not statistically significant. Double-labeling immunofluorescence showed that CD3-positive granzyme B–negative helper T cells expressed Foxp3. In small cell intestinal lymphoma cases, the overall survival of dogs with a high Treg density was significantly worse than that of dogs with a normal Treg density. These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.

[1]  M. Kiupel,et al.  Distinguishing Intestinal Lymphoma From Inflammatory Bowel Disease in Canine Duodenal Endoscopic Biopsy Samples , 2015, Veterinary pathology.

[2]  S. Hartmann,et al.  Frequencies of regulatory T cells in the peripheral blood of dogs with primary immune-mediated thrombocytopenia and chronic enteropathy: a pilot study. , 2014, Veterinary journal.

[3]  Yu-Mei Chang,et al.  Dissecting the Regulatory Microenvironment of a Large Animal Model of Non-Hodgkin Lymphoma: Evidence of a Negative Prognostic Impact of FOXP3+ T Cells in Canine B Cell Lymphoma , 2014, PloS one.

[4]  H. Tsujimoto,et al.  Intestinal Protease-Activated Receptor-2 and Fecal Serine Protease Activity are Increased in Canine Inflammatory Bowel Disease and May Contribute to Intestinal Cytokine Expression , 2014, The Journal of veterinary medical science.

[5]  G. Rossi,et al.  Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease , 2014, PloS one.

[6]  S. Sakaguchi,et al.  Regulatory T cells in cancer immunotherapy. , 2014, Current opinion in immunology.

[7]  D. Yoo,et al.  Evaluation of FOXP3 expression in canine mammary gland tumours. , 2014, Veterinary and comparative oncology.

[8]  J. Karbach,et al.  Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.

[9]  J. Sur,et al.  Infiltrating Foxp3+ regulatory T cells and histopathological features in canine classical and spermatocytic seminomas. , 2013, Reproduction in domestic animals = Zuchthygiene.

[10]  Kenji Nakamura,et al.  Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease. , 2012, Veterinary journal.

[11]  K. Odunsi,et al.  CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. , 2012, Cancer research.

[12]  Kenji Nakamura,et al.  Increased expression of fractalkine and its receptor CX3CR1 in canine inflammatory bowel disease and their possible role in recruitment of intraepithelial lymphocytes. , 2012, Veterinary immunology and immunopathology.

[13]  G. Schiechl,et al.  Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation , 2012, BMC Gastroenterology.

[14]  J. Sur,et al.  Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas. , 2012, Veterinary journal.

[15]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[16]  M. Hewicker-Trautwein,et al.  Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs , 2012, Veterinary Research.

[17]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[18]  S. Dow,et al.  Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma. , 2012, Veterinary immunology and immunopathology.

[19]  Yi Wang,et al.  Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease , 2011, Journal of digestive diseases.

[20]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[21]  D. Campbell,et al.  Phenotypical and functional specialization of FOXP3+ regulatory T cells , 2011, Nature Reviews Immunology.

[22]  C. Grant,et al.  Phenotypic and functional characterization of a CD4+ CD25high FOXP3high regulatory T‐cell population in the dog , 2011, Immunology.

[23]  M. Kiupel,et al.  Diagnostic Algorithm to Differentiate Lymphoma From Inflammation in Feline Small Intestinal Biopsy Samples , 2011, Veterinary pathology.

[24]  S. Dow,et al.  Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. , 2010, Journal of veterinary internal medicine.

[25]  T. Kadosawa,et al.  Flow Cytometric Analysis of Peripheral Blood and Tumor-Infiltrating Regulatory T Cells in Dogs with Oral Malignant Melanoma , 2010, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[26]  M. Yukawa,et al.  Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma , 2010, Microbiology and immunology.

[27]  M. Okuda,et al.  Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4+CD25 +Foxp3+ cells in canine peripheral blood. , 2009, The Journal of veterinary medical science.

[28]  H. Tsujimoto,et al.  Sensitivity for the detection of a clonally rearranged antigen receptor gene in endoscopically obtained biopsy specimens from canine alimentary lymphoma. , 2009, The Journal of veterinary medical science.

[29]  M. Yukawa,et al.  Increase of regulatory T cells in the peripheral blood of dogs with metastatic tumors , 2009, Microbiology and immunology.

[30]  S. Dow,et al.  Changes in regulatory T cells in dogs with cancer and associations with tumor type. , 2009, Journal of veterinary internal medicine.

[31]  M. A. Curotto de Lafaille,et al.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? , 2009, Immunity.

[32]  A. O'Connor,et al.  Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. , 2009, Comparative medicine.

[33]  J. Blay,et al.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.

[34]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[35]  A. Jergens,et al.  Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. , 2008, Journal of comparative pathology.

[36]  A. Gröne,et al.  Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. , 2007, Journal of veterinary internal medicine.

[37]  Zhao-You Tang,et al.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Zheng Zhang,et al.  Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.

[39]  M. Day,et al.  Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. , 2007, Veterinary immunology and immunopathology.

[40]  S. Dow,et al.  Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. , 2007, Veterinary immunology and immunopathology.

[41]  Stephen B Fox,et al.  Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  F. Powrie,et al.  Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1 , 2006, The Journal of Immunology.

[43]  H. Nawata,et al.  An Inverse Correlation of Human Peripheral Blood Regulatory T Cell Frequency with the Disease Activity of Ulcerative Colitis , 2006, Digestive Diseases and Sciences.

[44]  S. Ziegler.  FOXP3: of mice and men. , 2006, Annual review of immunology.

[45]  Gerd Ritter,et al.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. A. Curotto de Lafaille,et al.  Oral tolerance in the absence of naturally occurring Tregs. , 2005, The Journal of clinical investigation.

[47]  T. Giese,et al.  Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.

[48]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[49]  D. Zélénika,et al.  Induction of foxP3+ Regulatory T Cells in the Periphery of T Cell Receptor Transgenic Mice Tolerized to Transplants1 , 2004, The Journal of Immunology.

[50]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[51]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[52]  J. Shimizu,et al.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.

[53]  T. Fujita,et al.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. , 1999, Cancer research.

[54]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[55]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[56]  H. Weiner,et al.  Oral tolerance , 2011, Immunological reviews.

[57]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[58]  H. Tsujimoto,et al.  Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease. , 2013, Journal of veterinary internal medicine.

[59]  S. Lange,et al.  Phenotypic and functional characterization of freshly isolated and expanded canine regulatory T cells. , 2011, Experimental animals.

[60]  D. Thamm,et al.  Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. , 2002, Journal of veterinary internal medicine.

[61]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[62]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[63]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[64]  M. Sporn,et al.  Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. , 1992, Proceedings of the National Academy of Sciences of the United States of America.